The British Society for Nanomedicine (BSNM) is proud to collaborate with SELECTBIO in the organisation of Nanomedicine 2014. BSNM is a registered charity, created to allow open access for industry, academia, clinicians and the public to news and details of on-going nanomedicine research throughout the UK and beyond. A key aim of BSNM is the provision of forums for scientists to disseminate their latest advances and highlight their work to the wider scientific community. The exciting Nanomedicine 2014 programme will provide insight across a number of emerging nanotechnologies that span from treatment to diagnosis. The programme includes the use of solid drug nanosuspensions for improving oral bioavailability and for sustained release formulations, recent developments in targeting nanoparticles through the use of aptamers conjugated to their surface and progress in siRNA delivery as well as cell and particle imaging. The Conference Chair is Dr Andrew Owen, Professor of Pharmacology and Chair of the British Society for Nanomedicine, University of Liverpool.
Attending this event will provide you with excellent opportunities for networking with like minded peers, helping you to find solutions and build collaborations.
Check out our 2for1 offer!